Kanzhun Reports Strong 2025 Financials, Authorizes $400M Buyback, Initiates Annual Dividend, and Mitigates Delisting Risk

summarizeSummary

Kanzhun Ltd reported strong 2025 financial results, authorized a new $400 million share repurchase program, initiated an annual dividend policy, and confirmed reduced delisting risk under the HFCAA.

check_boxKey Events

• Strong 2025 Financial Performance

  Total revenues increased by 12.4% to RMB8.3 billion (US$1.2 billion) in 2025. Net income surged by 71.7% to RMB2.7 billion (US$384.7 million), and income from operations grew by 110.1% to RMB2.5 billion (US$352.4 million).

• Substantial Share Repurchase Program Authorized

  The board of directors approved amendments in March 2026 to extend the existing share repurchase program through August 2027, authorizing repurchases of up to an additional US$400 million of shares.

• New Annual Dividend Policy Initiated

  An annual dividend policy was approved in August 2025, with an intent to distribute no less than 50% of the company's adjusted net income for dividends and share repurchases for the next three years starting 2026. An annual cash dividend of US$0.084 per Class A ordinary share (US$0.168 per ADS), totaling approximately US$77.9 million, was approved for 2025.

• Reduced HFCAA Delisting Risk

  The company was not identified as a Commission-Identified Issuer under the Holding Foreign Companies Accountable Act (HFCAA) for the fiscal years ended December 31, 2022, 2023, and 2024, and does not expect to be for 2025, following the PCAOB's ability to inspect audit firms in China.

auto_awesomeAnalysis

Kanzhun Ltd's annual 20-F filing reveals robust financial performance for 2025, with significant increases in revenue, net income, and operating income. The company also announced a substantial capital return strategy, including the authorization of a new $400 million share repurchase program and the initiation of an annual dividend policy targeting at least 50% of adjusted net income. Furthermore, the filing confirms the company was not identified as a Commission-Identified Issuer under the HFCAA for 2022-2025, significantly reducing delisting concerns for investors in China-based ADRs. These combined factors signal strong operational health, management confidence, and a commitment to enhancing shareholder value, while also addressing a key regulatory overhang.